FDA Approves Extended-Release Tofacitinib (Xeljanz XR) for Rheumatoid Arthritis

FDA Approves Extended-Release Tofacitinib (Xeljanz XR) for Rheumatoid Arthritis

The FDA has given the green light to extended-release tofacitinib citrate tablets (Xeljanz XR, Pfizer) for the once-daily treatment of moderate-to-severe rheumatoid arthritis (RA) in patients who have had an inadequate response to or are intolerant of …

(Visited 4 times, 1 visits today)
6
Like
Save

Comments

Comments are disabled for this post.